---
title: "CVS stock: TD Cowen warns of bottom-line pressure for CVS Health amid star ratings setback"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/301395346.md"
description: "TD Cowen warns that CVS Health faces bottom-line pressure due to weaker 2027 Medicare Advantage Star Ratings, estimating a $0.41 per share reduction in adjusted earnings for 2028. While CVS shares dipped 1.8%, analysts maintain bullish sentiment with a consensus price target of $115.76. In contrast, rival Humana surged 15% after its largest plan improved to four stars, highlighting the financial impact of rating changes on insurer profitability."
datetime: "2026-10-09T11:49:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/301395346.md)
  - [en](https://longbridge.com/en/news/301395346.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/301395346.md)
generator: "portal-rs"
---

# CVS stock: TD Cowen warns of bottom-line pressure for CVS Health amid star ratings setback

・TD Cowen estimates 70% of CVS’ Medicare Advantage members will be enrolled in plans rated four stars or higher, down from 82% in 2026. ・The brokerage expects the weaker ratings to reduce CVS’ adjusted earnings by $0.41 per share in 2028. ・Humana emerged as a winner after its largest Medicare Advantage contract improved from 3.5 to four stars. CVS ...

### Related Stocks

- [CVS.US](https://longbridge.com/en/quote/CVS.US.md)
- [HUM.US](https://longbridge.com/en/quote/HUM.US.md)

## Related News & Research

- [Humana (OM:HUM) Stock Shrugs Off Q3 Earnings Rebound As Margin Questions Linger](https://longbridge.com/en/news/302794607.md)
- [UnitedHealthcare, Humana Medicare Advantage cancellations to affect 1 million](https://longbridge.com/en/news/302755563.md)
- [Ambea closes Humana offer with 97.99% acceptance](https://longbridge.com/en/news/301996188.md)
- [CVS Agrees to $315 Million Settlement Over Alleged Illegal Opioid Prescriptions](https://longbridge.com/en/news/301843746.md)
- [Humana Enters Joint Venture With BlackRock To Manage 150 Centerwell Clinics - SEC Filing](https://longbridge.com/en/news/301695451.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**